In an in vivo “stress test” in which tumor burden is escalated to reveal CAR T-cell functional limits, PRDM1 KO CAR T-cells showed comparable antitumor activity to AAVS1 KO CAR T-cells (Fig. 4C and D). The gene discussed is PRDM1; the disease is neoplasm.